Startups
Topas Therapeutics
Develops nanoparticle-based medicines intended to establish antigen-specific immune tolerance in the liver for autoimmune and immune-mediated diseases.
Team
Alex MarshallChief Business Officer |
Anne BurgerCFO |
 Christoph KocherSupervisory Board Member |
Erich GreinerSupervisory Board Chairman |
Hugo FryCEO |
Karl ZiegelbauerSupervisory Board Member |
Marc LohrmannSupervisory Board Member |
 Michael WackerSupervisory Board Member |
Sebastian KreuzSupervisory Board Member |
Stefan HerrSupervisory Board Member |